PRCT
PROCEPT BioRobotics Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth +18.2% ·
share flow +7.8% ·
net new positions +15.4%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 94 | +5 | 33.31M | $752.45M | +11 | −5 |
| Q1 2026 | 91 | -1 | 33.28M | $833.46M | +12 | −14 |
| Q4 2025 | 93 | +1 | 39.36M | $1.24B | +3 | −1 |
| Q3 2025 | 16 | -3 | 25.33M | $904.19M | — | −3 |
| Q2 2025 | 16 | 0 | 23.48M | $1.35B | +1 | −1 |
| Q1 2025 | 13 | +2 | 6.67M | $388.41M | +2 | — |
| Q4 2024 | 11 | 0 | 6.19M | $498.09M | +1 | −1 |
| Q3 2024 | 10 | -1 | 3.73M | $299.03M | — | −1 |
| Q2 2024 | 11 | — | 4.04M | $246.80M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 1.19M | -0.1% | $69.17M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.18M | +1.7% | $68.98M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 1.18M | +1.7% | $68.98M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.06M | +47.9% | $61.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.06M | +47.9% | $61.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 962.24K | -35.5% | $56.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 962.24K | -35.5% | $56.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 962.24K | -35.5% | $56.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 962.24K | -35.5% | $56.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 542.99K | +88.6% | $31.63M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 480.69K | +35.9% | $28.01M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 428.90K | -29.4% | $24.99M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 314.47K | +12.9% | $18.32M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Baillie Gifford ✦ | 313.88K | New | $18.29M | 0.0% | New | 1 | SEC ↗ |
| 15 | Baillie Gifford ✦ | 313.88K | New | $18.29M | 0.0% | New | 1 | SEC ↗ |
| 16 | Baillie Gifford ✦ | 313.88K | New | $18.29M | 0.0% | New | 1 | SEC ↗ |
| 17 | Baillie Gifford ✦ | 313.88K | New | $18.29M | 0.0% | New | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 114.82K | +1186.1% | $6.69M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 114.82K | +1186.1% | $6.69M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Marshall Wace ✦ | 114.82K | +1186.1% | $6.69M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 50.00K | New | $2.91M | 0.0% | New | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 18.89K | +7.3% | $1.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 18.89K | +7.3% | $1.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 18.89K | +7.3% | $1.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 18.89K | +7.3% | $1.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 18.89K | +7.3% | $1.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | Citadel Advisors ✦ | 12.95K | -82.5% | $754,350 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Baillie Gifford | $18.29M | 0.0% |
| Baillie Gifford | $18.29M | 0.0% |
| Baillie Gifford | $18.29M | 0.0% |
| Baillie Gifford | $18.29M | 0.0% |
| Adage Capital Partners | $2.91M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 254 holders, 55.53M shares, $1.28B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer, Director · President, CEO · 23.90K sh @ 20.85 · $498,315
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology